Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | BRD9 | Q9H8M2 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | TAF1 | P21675 | 1/20 | 0.32 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | KDM6A | O15550 | 1/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KDM5C | P41229 | 1/20 | 0.31 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.31 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL439647 | 0.71 | — | — | |
| SCHEMBL31227892 | 0.70 | — | — | |
| SCHEMBL27952255 | 0.70 | PIK3CB (0.41) | CRBNBRD9BRD4TAF1BRPF1 | |
| SCHEMBL20611026 | 0.70 | — | — | |
| SCHEMBL23128404 | 0.70 | — | — | |
| SCHEMBL25428969 | 0.70 | — | — | |
| SCHEMBL11250319 | 0.70 | — | — | |
| Iodide SCHEMBL29172953 | 0.68 | PIK3CB (0.40) | CRBNBRD9BRD4TAF1BRPF1 | |
| SCHEMBL3682057 | 0.67 | — | — | |
| SCHEMBL15360079 | 0.67 | SMPD3 (0.44) | CRBNBRD9BRD4TAF1BRPF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10385100-B2 | Compositions and methods for recognition of RNA using triple helix forming peptide nucleic acids | The Research Foundation for the State University o (US) | 2019-08-20 | — | — | US | disclosed |
| US-10260089-B2 | Compositions and methods for recognition of RNA using triple helical peptide nucleic acids | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 2019-04-16 | — | — | US | disclosed |
| US-20170009280-A1 | COMPOSITIONS AND METHODS FOR RECOGNITION OF RNA USING TRIPLE HELICAL PEPTIDE NUCLEIC ACIDS | UNIV NEW YORK STATE RES FOUND (US) | 2017-01-12 | — | — | US | disclosed |
| US-20140206838-A1 | COMPOSITIONS AND METHODS FOR RECOGNITION OF RNA USING TRIPLE HELICAL PEPTIDE NUCLEIC ACIDS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2014-07-24 | — | — | US | disclosed |
| CN-1506494-A | Non-electrolytic goldplating liquid | �ض���ѧ��ʽ���� | 2004-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170009280-A1 | COMPOSITIONS AND METHODS FOR RECOGNITION OF RNA USING TRIPLE HELICAL PEPTIDE NUCLEIC ACIDS | TARBP1, TRDMT1, ADAR | CRBN 4159/4885BRD9 1095/4885BRD4 2901/4885 |
| US-10260089-B2 | Compositions and methods for recognition of RNA using triple helical peptide nucleic acids | TARBP1, TRDMT1, ADAR | CRBN 4159/4885BRD9 1095/4885BRD4 2901/4885 |
| US-10385100-B2 | Compositions and methods for recognition of RNA using triple helix forming peptide nucleic acids | TARBP1, TRDMT1, NSUN3 | CRBN 4224/4885BRD9 1110/4885BRD4 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.